Diet Phytochemical Index: Application in Patients under Oncological Treatment

Detalhes bibliográficos
Autor(a) principal: Melo, Marina Maria de Martino
Data de Publicação: 2022
Outros Autores: Pugliesi, Amanda Cristina Torralbo, Paula, Maisa Rodrigues de, Maniglia, Fabíola Pansani
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/2614
Resumo: Introduction: Cancer treatment causes adverse effects that can change food consumption and consequently the intake of vitamins, fiber and phytochemicals. Objective: To apply the dietary Phytochemical Index (PI) in the food records of patients undergoing cancer treatment. Method: Cross-sectional study with individuals in cancer treatment. The participants’ sociodemographic and clinical information was collected to characterize the population. Feeding was obtained through a 24-hour dietary recall and entered into the Nutrabem Pro® software to obtain macro and microchemical values, as well as phytochemical data. To evaluate the study with PI, the formula proposed by McCarty was applied. Results: Ten patients, predominantly females, with an average age of 58±2.1 years participated of the study. The overall mean of PI was 20.44±11.55, and the rising order of consumption was: lutein-zeaxanthin, alpha-carotene, lycopene, cryptoxanthin and beta-carotene. The foods that contributed the most for the intake of phytochemicals were: beetroot, carrots and Japanese pumpkin for beta and alpha-carotene; orange and papaya for beta-cryptoxanthin; tomato sauce, watermelon and papaya for lycopene; chicory and beetroot for lutein/zeaxanthin; and apple, banana and olive oil for phytosterol. PI was not associated with sociodemographic and clinical variables of the population. Conclusion: Patients in cancer treatment had a low consumption of phytochemicals. This result is consistent with an insufficient intake of fruits and vegetables, as they represent the main sources of carotenoids in meals, in addition to the low consumption of oilseeds and seeds, which are an important source of phytosterols.
id INCA-1_5511221efbb79c7d0391c4764658a412
oai_identifier_str oai:rbc.inca.gov.br:article/2614
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Diet Phytochemical Index: Application in Patients under Oncological TreatmentÍndice Fitoquímico Dietético: Aplicación con Pacientes en Tratamiento OncológicoÍndice de Fitoquímicos da Dieta: Aplicação com Pacientes em Tratamento Oncológiconeoplasiascomportamento alimentarcompostos fitoquímicosdieta saudávelneoplasmsfeeding behaviorphytochemicalsdiet, healthyneoplasiasconducta alimentariacomposés phytochimiquesdieta saludableIntroduction: Cancer treatment causes adverse effects that can change food consumption and consequently the intake of vitamins, fiber and phytochemicals. Objective: To apply the dietary Phytochemical Index (PI) in the food records of patients undergoing cancer treatment. Method: Cross-sectional study with individuals in cancer treatment. The participants’ sociodemographic and clinical information was collected to characterize the population. Feeding was obtained through a 24-hour dietary recall and entered into the Nutrabem Pro® software to obtain macro and microchemical values, as well as phytochemical data. To evaluate the study with PI, the formula proposed by McCarty was applied. Results: Ten patients, predominantly females, with an average age of 58±2.1 years participated of the study. The overall mean of PI was 20.44±11.55, and the rising order of consumption was: lutein-zeaxanthin, alpha-carotene, lycopene, cryptoxanthin and beta-carotene. The foods that contributed the most for the intake of phytochemicals were: beetroot, carrots and Japanese pumpkin for beta and alpha-carotene; orange and papaya for beta-cryptoxanthin; tomato sauce, watermelon and papaya for lycopene; chicory and beetroot for lutein/zeaxanthin; and apple, banana and olive oil for phytosterol. PI was not associated with sociodemographic and clinical variables of the population. Conclusion: Patients in cancer treatment had a low consumption of phytochemicals. This result is consistent with an insufficient intake of fruits and vegetables, as they represent the main sources of carotenoids in meals, in addition to the low consumption of oilseeds and seeds, which are an important source of phytosterols.Introducción: El tratamiento del cáncer provoca efectos adversos que pueden modificar el consumo de alimentos y consecuentemente la ingesta de vitaminas, minerales, fibra y fitoquímicos. Objetivo: Aplicar el Índice Fitoquímico dietético (IF) en los registros alimentarios de pacientes en tratamiento oncológico. Método: Estudio transversal con individuos en tratamiento oncológico. Se recopiló la información sociodemográfica y clínica de los participantes para caracterizar la población. Los datos alimentarios se obtuvieron a través de un registro alimentario de 24 horas y se ingresaron al software Nutrabem Pro® para obtener valores de macro y micronutrientes, así como fitoquímicos. Para evaluar la FI se aplicó la fórmula propuesta por McCarty. Resultados: Participaron del estudio 50 pacientes, predominantemente del sexo femenino, con una edad media de 58±12,1 años. La media general de FI fue de 20,44±11,55, y el orden creciente de consumo fue: luteína-zeaxantina, alfacaroteno, licopeno, criptoxantina y betacaroteno. Los alimentos que más contribuyeron a la ingesta de fitoquímicos fueron: remolacha, zanahoria y calabaza japonesa para beta y alfacaroteno; naranja y papaya para betacriptoxantina; salsa de tomate, sandía y papaya para licopeno; achicoria y remolacha para luteína/zeaxantina; y manzana, plátano y aceite de oliva para fitosterol. El FI no se asoció con las variables sociodemográficas y clínicas de la población. Conclusión: Los pacientes en tratamiento oncológico presentaron un bajo consumo de fitoquímicos. Este resultado es consistente con el consumo insuficiente de frutas y verduras, que representan las principales fuentes de carotenoides en las comidas, además del bajo consumo de oleaginosas y semillas, que son una fuente importante de fitoesteroles.Introdução: O tratamento do câncer provoca efeitos adversos que podem alterar o consumo alimentar e, consequentemente, a ingestão de vitaminas, minerais, fibras e fitoquímicos. Objetivo: Aplicar o Índice de Fitoquímicos (IF) da dieta nos registros alimentares de pacientes em tratamento oncológico. Método: Estudo transversal com indivíduos em tratamento oncológico. Foram coletadas informações sociodemográficas e clínicas dos participantes para caracterização da população. Os dados alimentares foram obtidos por meio de recordatório alimentar de 24 horas e inseridos no software Nutrabem Pro® para obtenção dos valores de macro e micronutrientes, bem como dos fitoquímicos. Para avaliar o IF, aplicou-se a fórmula proposta por McCarty. Resultados: Participaram do estudo 50 pacientes predominantemente do sexo feminino e com média da idade de 58±12,1 anos. A média geral do IF foi de 20,44±11,55, e a ordem crescente de consumo foi: luteína-zeaxantina, alfacaroteno, licopeno, criptoxantina e betacaroteno. Os alimentos que mais contribuíram para a ingestão dos fitoquímicos foram: beterraba, cenoura e abóbora-japonesa para beta e alfacaroteno; laranja e mamão para betacriptoxantina; molho de tomate, melancia e mamão para licopeno; almeirão e beterraba para luteína/zeaxantina; e maçã, banana e azeite para fitoesterol. O IF não se associou com as variáveis sociodemográficas e clínicas da população. Conclusão: Os pacientes em tratamento oncológico apresentaram baixo consumo de fitoquímicos. Esse resultado condiz com a ingestão insuficiente de frutas e hortaliças, as quais representam as principais fontes de carotenoides nas refeições, além do baixo consumo de oleaginosas e sementes, que configuram uma importante fonte de fitoesteróis.INCA2022-10-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/261410.32635/2176-9745.RBC.2022v68n4.2614Revista Brasileira de Cancerologia; Vol. 68 No. 4 (2022): Oct./Nov./Dec.; e-132614Revista Brasileira de Cancerologia; Vol. 68 Núm. 4 (2022): oct./nov./dic.; e-132614Revista Brasileira de Cancerologia; v. 68 n. 4 (2022): out./nov./dez.; e-1326142176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/2614/2276https://rbc.inca.gov.br/index.php/revista/article/view/2614/3006https://rbc.inca.gov.br/index.php/revista/article/view/2614/2459Copyright (c) 2022 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMelo, Marina Maria de MartinoPugliesi, Amanda Cristina TorralboPaula, Maisa Rodrigues deManiglia, Fabíola Pansani2023-07-06T17:55:42Zoai:rbc.inca.gov.br:article/2614Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-07-06T17:55:42Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Diet Phytochemical Index: Application in Patients under Oncological Treatment
Índice Fitoquímico Dietético: Aplicación con Pacientes en Tratamiento Oncológico
Índice de Fitoquímicos da Dieta: Aplicação com Pacientes em Tratamento Oncológico
title Diet Phytochemical Index: Application in Patients under Oncological Treatment
spellingShingle Diet Phytochemical Index: Application in Patients under Oncological Treatment
Melo, Marina Maria de Martino
neoplasias
comportamento alimentar
compostos fitoquímicos
dieta saudável
neoplasms
feeding behavior
phytochemicals
diet, healthy
neoplasias
conducta alimentaria
composés phytochimiques
dieta saludable
title_short Diet Phytochemical Index: Application in Patients under Oncological Treatment
title_full Diet Phytochemical Index: Application in Patients under Oncological Treatment
title_fullStr Diet Phytochemical Index: Application in Patients under Oncological Treatment
title_full_unstemmed Diet Phytochemical Index: Application in Patients under Oncological Treatment
title_sort Diet Phytochemical Index: Application in Patients under Oncological Treatment
author Melo, Marina Maria de Martino
author_facet Melo, Marina Maria de Martino
Pugliesi, Amanda Cristina Torralbo
Paula, Maisa Rodrigues de
Maniglia, Fabíola Pansani
author_role author
author2 Pugliesi, Amanda Cristina Torralbo
Paula, Maisa Rodrigues de
Maniglia, Fabíola Pansani
author2_role author
author
author
dc.contributor.author.fl_str_mv Melo, Marina Maria de Martino
Pugliesi, Amanda Cristina Torralbo
Paula, Maisa Rodrigues de
Maniglia, Fabíola Pansani
dc.subject.por.fl_str_mv neoplasias
comportamento alimentar
compostos fitoquímicos
dieta saudável
neoplasms
feeding behavior
phytochemicals
diet, healthy
neoplasias
conducta alimentaria
composés phytochimiques
dieta saludable
topic neoplasias
comportamento alimentar
compostos fitoquímicos
dieta saudável
neoplasms
feeding behavior
phytochemicals
diet, healthy
neoplasias
conducta alimentaria
composés phytochimiques
dieta saludable
description Introduction: Cancer treatment causes adverse effects that can change food consumption and consequently the intake of vitamins, fiber and phytochemicals. Objective: To apply the dietary Phytochemical Index (PI) in the food records of patients undergoing cancer treatment. Method: Cross-sectional study with individuals in cancer treatment. The participants’ sociodemographic and clinical information was collected to characterize the population. Feeding was obtained through a 24-hour dietary recall and entered into the Nutrabem Pro® software to obtain macro and microchemical values, as well as phytochemical data. To evaluate the study with PI, the formula proposed by McCarty was applied. Results: Ten patients, predominantly females, with an average age of 58±2.1 years participated of the study. The overall mean of PI was 20.44±11.55, and the rising order of consumption was: lutein-zeaxanthin, alpha-carotene, lycopene, cryptoxanthin and beta-carotene. The foods that contributed the most for the intake of phytochemicals were: beetroot, carrots and Japanese pumpkin for beta and alpha-carotene; orange and papaya for beta-cryptoxanthin; tomato sauce, watermelon and papaya for lycopene; chicory and beetroot for lutein/zeaxanthin; and apple, banana and olive oil for phytosterol. PI was not associated with sociodemographic and clinical variables of the population. Conclusion: Patients in cancer treatment had a low consumption of phytochemicals. This result is consistent with an insufficient intake of fruits and vegetables, as they represent the main sources of carotenoids in meals, in addition to the low consumption of oilseeds and seeds, which are an important source of phytosterols.
publishDate 2022
dc.date.none.fl_str_mv 2022-10-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/2614
10.32635/2176-9745.RBC.2022v68n4.2614
url https://rbc.inca.gov.br/index.php/revista/article/view/2614
identifier_str_mv 10.32635/2176-9745.RBC.2022v68n4.2614
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/2614/2276
https://rbc.inca.gov.br/index.php/revista/article/view/2614/3006
https://rbc.inca.gov.br/index.php/revista/article/view/2614/2459
dc.rights.driver.fl_str_mv Copyright (c) 2022 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 68 No. 4 (2022): Oct./Nov./Dec.; e-132614
Revista Brasileira de Cancerologia; Vol. 68 Núm. 4 (2022): oct./nov./dic.; e-132614
Revista Brasileira de Cancerologia; v. 68 n. 4 (2022): out./nov./dez.; e-132614
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042232778293248